We contribute to progress in medical therapy by advancing specialized leading-edge technology in new combinations and addressing unmet medical needs, enabling patients to enjoy a better quality of life.
Our pharmaceuticals business provides a wide range of pharmaceuticals and diagnostic reagents. As a specialized, R&D-centered operation, the development of new world-class drugs is advanced to offer innovative and unique therapeutic solutions in the fields of orthopedics, critical/intensive care, urology, the immune system, and the central nervous system.
Our medical care business contributes to the advancement of medical treatment worldwide via continuous innovation in various fields, including medical device systems that respond to unmet needs (such as chronic and acute renal disease, neurologic diseases and other intractable conditions), filters that improve the quality of blood transfusion products, and products that enable safe and efficient production of biotherapeutics and other medicines at the cutting edge of new drug development.
Our acute critical care business is based on world-leading resuscitation technology. Through our ZOLL family of products, we offer a comprehensive product portfolio that includes professional defibrillators and automated external defibrillators (AEDs), as well as a wearable defibrillator, portable ventilators, a highly efficient intravascular system for managing the core temperature of critically ill patients, and data management systems for care providers. We continue to expand operations in the field of acute critical care to enable better outcomes for more patients around the world.